Post Tags

Currently displaying posts matching the tag

News

  • MMS Holdings Inc. Funds $1 Million Zika Vaccine Development Award

    Posted on 3/14/2016 6:00 AM

    Canton, MI — MMS Holdings Inc. a specialty data-focused CRO headquartered in Canton, MI has announced a $1M award toward the development of a Zika vaccine. The award is being offered as data services to qualified pharmaceutical companies supporting the commercial development of a vaccine for approval in the United States and/or other global regulatory markets. MMS CSO, Dr. Uma Sharma said “Our experience with clinical data, especially in the area of vaccines, puts MMS in a strong position to su

    View Post

  • MMS Holdings Inc. Announces Expansion of Asia Operations In Hyderabad, India

    Posted on 1/26/2016 11:00 AM

    Canton, MI — MMS Holdings Inc. (www.mmsholdings.com) is pleased to announce the opening of a new office in Hyderabad, India. The company’s Asia headquarters are located in Bangalore, India and the company’s ability to deliver exceptional quality across all of its service offerings has resulted in steady growth for the company. According to Prasad Koppolu, Vice President for MMS Holdings Inc., “Our clients have come to depend on us to deliver quality across all of our global office locations and

    View Post

  • Comprehensive Oncology Support Services

    Posted on 8/18/2014 11:57 AM

    MMS Holdings and Oncology Trials Insights form Strategic Partnership to Deliver Comprehensive Oncology Support Services

    View Post

  • Prescription to Over the Counter Switch

    Posted on 7/1/2014 4:22 PM

    There are many regulatory considerations an organization should evaluate when transitioning a prescription drug to an Over the Counter (OTC) drug in the United States. Is the product safe in the OTC environment? Do the drug’s benefits and risks remain favorable? Does the potential for misuse and abuse remain low as an OTC drug? Can consumers adequately self-diagnose? Can consumers appropriately select and use the product in accordance with product labeling? Do users need the assistance o

    View Post

  • MMS Holdings Inc. partners with Wayne State University to place Graduate Students in Scientific Summer Internship Program

    Posted on 6/11/2014 11:00 AM

    MMS Holdings Inc., a clinical research organization that focuses on regulatory submission support for the pharmaceutical, biotech and medical device industries, and the Wayne State University Graduate School announced today the creation of a scientific internship program to broaden career opportunities for graduate students. In September 2013, the WSU Graduate School won an award from the National Institutes of Health to initiate the Broadening Experience in Scientific Training program. The goa

    View Post

  • Knopp Biosciences Partners with MMS Holdings Inc. to Manage Pharmacovigilance Services

    Posted on 8/1/2013 11:00 AM

    MMS Holdings Inc. today announced that it has been selected to partner with Knopp Biosciences to provide best-in-class pharmacovigilance services in support of their compound, dexpramipexole. The MMS Holdings team offers an efficient, adaptable model that enables increased productivity, enhances internal and external reporting, and allows sponsors more time to focus on strategy rather than day-to-day activities. MMS Holdings has strong processes and systems in place as well as experienced, quali

    View Post

  • DATATRAK signs Specialty CRO, MMS Holdings Inc., as DATATRAK Connect™ Partner

    Posted on 6/25/2013 11:00 AM

    DATATRAK International, Inc. (OTCQX: DTRK), a leader in developing cloud-based, unified eClinical® technologies and delivering related services for the clinical trials industry, today announced MMS Holdings Inc. is now a DATATRAK Connect™ Partner.  MMS Holdings Inc. is a specialty Contract Research Organization (CRO) who focuses on regulatory submission support for the pharmaceutical, biotech and medical device industries. Known for their strong industry experience and scientific approach to dr

    View Post

  • MMS Set to Expand Disclosure Services with Registry Reporting Software TrialAssure™

    Posted on 3/1/2013 11:00 AM

    MMS Holdings Inc. today announced that it has successfully executed disclosure management services for several clients and is poised to make strides in this area with its proprietary software, TrialAssure™. TrialAssure™ is a workflow management system that supports the reporting of clinical, financial and company information. In addition to the software, MMS has the technical leadership in the disclosure arena. Joe Archer leads the disclosure teams at MMS and brings with him a depth of technica

    View Post

Regulatory Submission Support Based on Strong Science and Strength of Process. The difference is in the data!

Contact Us Today!